More local manufacturing
June 6, 2013
PHARMACEUTICAL manufacture
in Australia is continuing to enjoy a
resurgence, with the opening this
month of a new $8 million Mega
Lifesciences Public Company facility
in Pakenham, Victoria.
Mega Lifesciences was established
in Thailand in 1982, and employs
more than 4,000 people globally
with a turnover of about $200m.
The company opened its first
Australian manufacturing plant
in Dandenong in 2002, with the
company saying that the business
has gone from strength to
strength, with the recent increased
investment “bucking the current
trend of Australian manufacturing
taking production offshore”.
Mega Lifesciences established the
first soft gel capsule manufacturing
plant in Thailand, and was granted
its TGA license almost 20 years ago.
Managing Director John Farley
said global growth and demand for
the company’s liquid filled tablets
had prompted the decision to
relocate most manufacture of its
tablets and hard shell capsules from
Thailand to Melbourne.
“The decision to expand the
Australian manufacturing operation
is testimony to the quality and
consistency of the products
already produced in Australia,”
he said, with the country having
an excellent reputation for
manufactured health care products
in overseas markets.
“We believe that the Pakenham
plant will be a cornerstone of
our global growth strategy as we
continue to invest for the future,”
Farley added.
And Mega Lifesciences ceo Vivek
Dhawan said that despite the
currently high Australian dollar, the
local investment is expected to be a
“good long-term business”.
He said he also expected the local
demand for contract manufacturing
services to continue to grow.
“Our business model means we
are highly competitive providing
small and mid size companies
products with speed and
efficiency,” he said.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jun 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jun 13